Your browser doesn't support javascript.
loading
α-synuclein (SNCA) but not dynamin 3 (DNM3) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain.
Fernández-Santiago, Rubén; Garrido, Alicia; Infante, Jon; González-Aramburu, Isabel; Sierra, María; Fernández, Manel; Valldeoriola, Francesc; Muñoz, Esteban; Compta, Yaroslau; Martí, María-José; Ríos, José; Tolosa, Eduardo; Ezquerra, Mario.
Affiliation
  • Fernández-Santiago R; Laboratory of Parkinson Disease and Other Neurodegenerative Movement Disorders, Clinical and Experimental Research, Department of Neurology, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
  • Garrido A; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Madrid, Spain.
  • Infante J; Movement Disorders Unit, Department of Neurology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
  • González-Aramburu I; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Madrid, Spain.
  • Sierra M; Movement Disorders Unit, Department of Neurology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain.
  • Fernández M; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Madrid, Spain.
  • Valldeoriola F; Movement Disorders Unit, Department of Neurology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain.
  • Muñoz E; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Madrid, Spain.
  • Compta Y; Movement Disorders Unit, Department of Neurology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain.
  • Martí MJ; Laboratory of Parkinson Disease and Other Neurodegenerative Movement Disorders, Clinical and Experimental Research, Department of Neurology, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
  • Ríos J; Laboratory of Parkinson Disease and Other Neurodegenerative Movement Disorders, Clinical and Experimental Research, Department of Neurology, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
  • Tolosa E; Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Madrid, Spain.
  • Ezquerra M; Movement Disorders Unit, Department of Neurology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
Mov Disord ; 33(4): 637-641, 2018 04.
Article de En | MEDLINE | ID: mdl-29473656
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Parkinson / Régulation de l'expression des gènes / Âge de début / Alpha-Synucléine / Leucine-rich repeat serine-threonine protein kinase-2 Type d'étude: Diagnostic_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Mov Disord Sujet du journal: NEUROLOGIA Année: 2018 Type de document: Article Pays d'affiliation: Espagne
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Parkinson / Régulation de l'expression des gènes / Âge de début / Alpha-Synucléine / Leucine-rich repeat serine-threonine protein kinase-2 Type d'étude: Diagnostic_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Mov Disord Sujet du journal: NEUROLOGIA Année: 2018 Type de document: Article Pays d'affiliation: Espagne